Belgian Society on Thrombosis and Haemostasis

The Belgian Society on Thrombosis & Haemostasis, a non-profit medical research organization, seeks to:

  • Foster and advance science
    relating to thrombosis, haemostasis, and vascular biology
  • Provide a forum
    for discussion of these problems
  • Encourage research
    in these areas
  • Focus the attention of scientists
    of the several relevant disciplines on these matters
  • Foster the diffusion and exchange of ideas
    through meetings and publications

Learn more about BSTH

Scientific societies supported by BSTH 


For the World SCD day 2020, ERN-EuroBloodNet has collected SCD patients’ representatives’ testimonies into 2 videos: one about the importance of having a common unique patients’ voice in Europe and the other about engaging patients’ thoughts in research.

We invite you to watch them and share among the Society members! Let’s raise SCD Awareness together!

Royal Belgian Society of Laboratory Medicine

The Royal Belgian Society of Laboratory Medicine aims at representing and promoting the scientific and clinical interests of laboratory medicine in Belgium as well as clinical biology, biochemistry, hematology, microbiology and related new disciplines.

Belgian Journal of Hematology

The Belgian Journal of Hematology (BJH) is the official journal of the Belgian Society on Thrombosis and Haemostasis.

BJH is the journal for training of medical specialists working in the field of Haematology in Belgium or Luxembourg in the broadest sense.



Upcoming events

Virtual Meeting BSTH 2020 
Mechelen, Belgium

Gent, Belgium
(co-organised by BSTH)



More interesting international meetings:

Get involved and become a member of BSTH!

  • Open to all persons interested and working in the field of thrombosis and haemostasis in Belgium, including healthcare and research
  • Membership by paying yearly membership fees (deadline for the running year: November 26)
  • Corporate membership available
  • Clear membership benefits have been defined
  • Only members are eligible for BSTH grants, organizational positions or voting at BSTH General Assembly

More details about membership benefits and fees

Online registration for membership 2020

BSTH news

ISTH Statement on COVID-19 and Venous Thromboembolism (VTE)
BSTH contributed to this statement together with 70 other organizations around the world.

BSTH Virtual Meeting 2020
In light of the uncertainties surrounding the COVID-19 pandemic, the BSTH Board decided to postpone the annual meeting, and to replace it with a two-day virtual meeting. Our priority is to preserve our communities and their health and safety while continuing BSTH's tradition of advancing the frontiers of science and patient care in Thrombosis and Hemostasis. Details on our virtual meeting will be communicated soon. 

AHA/ISTH Scientific Statement:
Venous Thromboembolism Research Priorities 

Venous thromboembolism is a major cause of morbidity and mortality. The impact of the US Surgeon General’s The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism in 2008 has been lower than expected given the public health impact of this disease. This scientific statement highlights future research priorities in venous thromboembolism, developed by experts and a crowdsourcing survey across 16 scientific organizations.

Belgian consensus documents on Anticoagulation management in COVID-19 are available now!

ISTH came forward with  recommendations and practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected with COVID-19.
This is a living guidance document that will be updated weekly.


Coronavirus BSTH 2020-3.jpg

Presentations of Annual Meeting 2019
Presentations are available for download now (for participants only).


New Presidency
BSTH retrospect by the new president of BSTH.
Read more.

Follow us on Like us on LinkedIn Like us on Facebook!

© Copyright 2020 - Belgian Society on Thrombosis and Haemostasis - All rights reserved.